Can pathology diagnostic services for cancer be stratified and serve global health?

Cancer control in the Caribbean island countries and territories: some progress but the journey continues

(2019) Dingle Spence et al.   LANCET ONCOLOGY

Cancer control in the Pacific: big challenges facing small island states

(2019) Diana Sarfati et al.   LANCET ONCOLOGY

Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Peter Schmid et al.   LANCET ONCOLOGY

Practical Successes in Telepathology Experiences in Africa

(2018) Nathan D. Montgomery et al.   CLINICS IN LABORATORY MEDICINE

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

(2018) Andrew Tutt et al.   NATURE MEDICINE

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

(2018) Natalie C. Wu et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

(2018) William J. Gradishar et al.   Journal of the National Comprehensive Cancer Network

Cancer control planning: self-assessment for pre-planning, development, implementation and evaluation of national cancer control plans

(2018) Leslie S. Given et al.   CANCER CAUSES & CONTROL

NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care

(2016) Robert W. Carlson et al.   Journal of the National Comprehensive Cancer Network

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

(2016) Fatima Cardoso et al.   NEW ENGLAND JOURNAL OF MEDICINE

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

(2015) Rinath Jeselsohn et al.   Nature Reviews Clinical Oncology

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

(2015) Joseph A. Sparano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guideline implementation for breast healthcare in low- and middle-income countries

(2009) Cheng-Har Yip et al.   CANCER

Re-establishing a surgical pathology service in Kumasi, Ghana

(2009) Helge Stalsberg et al.   CANCER

Breast pathology guideline implementation in low- and middle-income countries

(2009) Shahla Masood et al.   CANCER

Guideline implementation for breast healthcare in low- and middle-income countries

(2009) Roman Shyyan et al.   CANCER

Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation

(2009) Alexandru Eniu et al.   CANCER

Guideline implementation for breast healthcare in low- and middle-income countries

(2009) Joe Harford et al.   CANCER